Acasti Pharma's (ACST) last three weeks of trading have been indicative of increasing investor interest. June 28th's closing at $2.83 represented a solid close above former resistance in the $2.70s that had been the stock's bane since December 2012, January of this year and multiple times in May and June. Reviewing the company's stock chart for 2013, March 21st's $2.10 closing lows have been followed by a bullish uptrend with 52-week closing highs of $3.00 on July 8th. When researching new investment candidates, SEC filings and corporate press releases around such peaks and dips can be very revealing and can reveal upcoming or even imminent catalysts. Although currently a somewhat illiquid stock, I believe investors with a...
Acasti Pharma: Increasing Investor Interest And Volatility Likely Cometh
Jul 9 2013, 14:28 | about: ACST
BOOKMARKED / READ LATER
Added to your bookmarks on the Seeking Alpha homepage